ICCM (ICCM) Stock Price & Analysis
ICCM (ICCM) fell 4.64% to USD 3.08 as of July 26, 2026 at 11:54 UTC, according to Nexqual real-time market data.
ICCM last closed at USD 3.23; the session ranged USD 3.01–3.3 on volume of 74,306 shares. Market capitalization is $10.55M, with a 52-week range of USD 2.12–42 (NCM). Source: Nexqual, July 26, 2026 at 11:54 UTC.
Key Statistics (as of July 26, 2026 at 11:54 UTC)
| Price | USD 3.08 |
|---|---|
| Change | ▼ 4.64% (down) |
| Previous Close | USD 3.23 |
| Open | USD 3.25 |
| Day Range | USD 3.01 – 3.3 |
| 52-Week Range | USD 2.12 – 42 |
| Volume | 74,306 shares |
| Market Cap | $10.55M |
| Exchange | NCM |
Technical Analysis (ICCM)
Nexqual's technical model rates ICCM "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 11:54 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.79 (neutral) |
| vs SMA50 | Below (USD 4.95) |
| MACD | -0.59 (negative) |
Analyst Ratings (ICCM)
Wall Street analysts rate ICCM "None" based on 3 analysts, with a mean price target of USD 30.5 (range USD 30–31.5), per Nexqual as of July 26, 2026 at 11:54 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 30.5 |
| High Target | USD 31.5 |
| Low Target | USD 30 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (ICCM)
| Next Earnings Date | 2026-08-12 |
|---|---|
| EPS Estimate | USD -1.38 |
| Revenue Estimate | $1.45M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -1.8 vs est -1.2 ▼ miss |
| 2025-12-31 | USD -1.8 vs est -1.2 ▼ miss |
| 2025-09-30 | USD -1.8 vs est -1.65 ▼ miss |
| 2025-06-30 | USD -1.8 vs est -1.95 ▲ beat |
Source: Nexqual, July 26, 2026 at 11:54 UTC.
Financials & Fundamentals (ICCM)
| Total Revenue | $3.56M |
|---|---|
| Revenue Growth (YoY) | +25.70% |
| Gross Margin | +36.55% |
| Operating Margin | -466.19% |
| Profit Margin | +0.00% |
| ROE | -217.23% |
| Debt / Equity | 1.64 |
| Current Ratio | 2.52 |
| Total Cash | $8.12M |
| Total Debt | $139,000 |
| Free Cash Flow | $-8.88M |
Source: Nexqual, July 26, 2026 at 11:54 UTC.
Financial Health Score (ICCM)
Nexqual rates ICCM's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 11:54 UTC.
| Growth | Mixed — Revenue +2.7% YoY (annual), slow |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $8M cash, no debt |
| Cash Flow | Weak — FCF negative: -$9M, burning cash |
| Efficiency | Critical — ROE -217%, ROA -80.3% |
Ownership (ICCM)
| Insider Ownership | +32.72% |
|---|---|
| Institutional Ownership | +3.74% |
| Shares Outstanding | 3.43M |
| Float | 1.74M |
| Short % of Float | +4.83% |
Source: Nexqual, July 26, 2026 at 11:54 UTC.
Leadership (ICCM)
ICCM is led by Eyal Shamir (age 64), CEO & Director, per Nexqual as of July 26, 2026 at 11:54 UTC.
| CEO & Director | Eyal Shamir (age 64) |
|---|---|
| Chief Operating Officer | Shay Levav (age 47) |
| Vice President of Business Development & Global Marketing | Tlalit Bussi Tel-Tzure (age 54) |
| Vice President of Sales for North America | Shad Good (age 47) |
| Chief Financial Officer | Meir Peleg (age 49) |
Major Backers & Investors (ICCM)
Notable institutional backers of ICCM include Armistice Capital, LLC, Gunderson Capital Management LLC, UBS Group AG, according to Nexqual as of July 26, 2026 at 11:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Armistice Capital, LLC | 2.64% |
| Gunderson Capital Management LLC | 0.58% |
| UBS Group AG | 0.15% |
Source: Nexqual, July 26, 2026 at 11:54 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| HSCS | HeartSciences Inc. | USD 2.39 | ▼ 4.4% |
| CMND | Clearmind Medicine Inc. | USD 1.61 | ▼ 3.59% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 4.28 | ▼ 2.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 11:54 UTC. This page is informational and not investment advice.